Ignite Creation Date:
2025-12-25 @ 1:20 AM
Ignite Modification Date:
2026-04-15 @ 2:28 AM
Study NCT ID:
NCT01998893
Status:
COMPLETED
Last Update Posted:
2014-12-03
First Post:
2013-11-25
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of MabThera/Rituxan (Rituximab) in Patients With Relapsed Centroblastic Centrocytic Non-Hodgkin's Lymphoma
Sponsor:
Hoffmann-La Roche
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
1997-01
Start Date Type:
None
Primary Completion Date:
2008-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2008-02
Completion Date Type:
ACTUAL
First Submit Date:
2013-11-25
First Submit QC Date:
None
Study First Post Date:
2013-12-02
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2014-10-30
Results First Submit QC Date:
None
Results First Post Date:
2014-11-04
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2014-11-17
Last Update Post Date:
2014-12-03
Last Update Post Date Type:
ESTIMATED